We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
Lexology logo
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 269

Jury ruled in Tuomey Healthcare retrial that the hospital violated the Stark Law and False Claims Act

  • King & Spalding LLP
  • -
  • USA
  • -
  • May 13 2013

On May 8, 2013, a jury concluded that Tuomey Healthcare System, Inc. (Tuomey), a community hospital in Sumter, S.C., violated the Stark Law for

Tuomey violates Stark Law and False Claims Act through physician employment agreements

  • Barnes & Thornburg LLP
  • -
  • USA
  • -
  • May 13 2013

After a retrial, a federal jury found South Carolina-based 242-bed Tuomey Healthcare System (Tuomey) guilty last week of violating the Stark Law and

How to minimize FCPA risk in health care acquisitions

  • Mintz Levin Cohn Ferris Glovsky and Popeo PC
  • -
  • USA
  • -
  • May 10 2013

When acquiring a health care company doing business abroad, there is no such thing as being too thorough with anti-corruption due diligence. The

Law enforcement in the health care industry: what do new cases against Novartis tell us?

  • Morvillo Abramowitz Grand Iason & Anello PC
  • -
  • USA
  • -
  • May 9 2013

In recent years, pharmaceutical companies have faced criminal investigations and charges in regard to alleged off-label marketing of prescription

New rule ups the ante for Medicare fraud whistleblowers

  • Littler Mendelson
  • -
  • USA
  • -
  • May 6 2013

Blowing the whistle on Medicare fraud may become dramatically more lucrative. On April 29, 2013, the Department of Health and Human Services (HHS

Amphastar’s qui tam suit against Aventis shows importance of patents

  • Fish & Richardson PC
  • -
  • USA
  • -
  • May 3 2013

In a recent ground-breaking qui tam ruling, a California federal court denied Aventis Pharma's (a division of Sanofi-Aventis) efforts to dismiss

Physician Payment Sunshine Act: considering the global implementation of data collection systems & reporting policies

  • Debevoise & Plimpton LLP
  • -
  • USA
  • -
  • April 29 2013

During the last decade, the Department of Justice (“DOJ”) and Securities and Exchange Commission (“SEC”) have aggressively investigated and

OIG determines that PODs are “inherently suspect” under the anti-kickback law

  • Hogan Lovells
  • -
  • USA
  • -
  • March 26 2013

In its strongest statement so far on the subject, the HHS Office of Inspector General (OIG) today released a Special Fraud Alert which concludes that

Healthcare fraud and abuse review 2012

  • Bass, Berry & Sims PLC
  • -
  • USA
  • -
  • March 22 2013

The previous year saw another record-setting recovery by the federal government in its efforts to combat healthcare fraud and abuse. Late last year

Publicly traded life sciences companies in the United States Remain an increasingly popular target of securities fraud class action lawsuits

  • Dechert LLP
  • -
  • USA
  • -
  • March 21 2013

The past year was particularly noteworthy with respect to the absolute and relative number of securities fraud class action lawsuits brought against